Determine the necessary mass, volume, or concentration for preparing a solution.
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
≥96% pour les flux de travail chromatographiques et analytiques sensibles nécessitant une interférence de ligne de base minimale.
A l'abri de la lumière,A conserver à -20°C Expédition Glacière + blocs de glace. Consultez le COA spécifique au lot pour les spécifications exactes.
SDS, COA, fiche technique et fiche de spécifications disponibles au téléchargement. COA spécifique au lot accessible via la recherche par numéro de lot.
Cité dans 0 publications à comité de lecture couvrant la chromatographie, la synthèse organique et les réactions de couplage croisé.
Document complet couvrant les dangers, la manipulation, le stockage et la conformité réglementaire.
<<<<<<< HEAD Télécharger la SDS → ======= Télécharger la SDS → >>>>>>> release248-p3Données qualité spécifiques au lot. Saisissez votre numéro de lot pour récupérer le COA exact.
Rechercher le COA →Résumé de référence rapide des spécifications et applications du produit.
Voir la fiche technique →Attributs de qualité complets et critères d'acceptation pour cette qualité.
Voir la fiche de spécifications →Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Benzenoids |
| Classe | Benzene and substituted derivatives |
| Subclass | Benzoic acids and derivatives |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Benzoic acids and derivatives |
| Alternative Parents | m-Xylenes Benzoyl derivatives Hydroxamic acids Organonitrogen compounds Organic oxides Hydrocarbon derivatives Carbonyl compounds |
| Molecular Framework | Aromatic homomonocyclic compounds |
| Substituents | Benzoic acid or derivatives - M-xylene - Xylene - Benzoyl - Hydroxamic acid - Carboxylic acid derivative - Organic nitrogen compound - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Organonitrogen compound - Carbonyl group - Aromatic homomonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as benzoic acids and derivatives. These are organic compounds containing a carboxylic acid substituent attached to a benzene ring. |
| External Descriptors | Not available |
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Article |
|---|---|---|---|
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 | |
| Certificate of Analysis | Sep 07, 2026 | L275949 |
| Solubilité | Soluble in DMSO |
|---|---|
| Poids moléculaire | 294.350 g/mol |
| XLogP3 | 1.800 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 8 |
| Exact Mass | 294.158 Da |
| Monoisotopic Mass | 294.158 Da |
| Topological Polar Surface Area | 87.700 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 326.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 1 |
No tested applications, protocols, or recommended dilutions are provided in the Product Data for this item.
General guidance for preparing working solutions (not item-specific):
For cell-based work, confirm media compatibility, serum binding, and cytotoxicity in pilot runs and adhere to institutional biosafety protocols. Refer to your assay kit or method SOPs for detailed steps.
General/literature context (no medical/clinical claims; not item-specific):
For specific potency values (IC50/Ki), isoform selectivity, and cell-permeability parameters, consult primary literature and verify against your experimental platform; these are assay-condition dependent.
This product is a bioactive small molecule rather than a buffering agent. Classical buffer systems (e.g., phosphate, HEPES, Tris) are used to formulate assay media in which LMK 235 is tested.
General guidance for preparing assay buffers (not item-specific):
Because LMK 235 is not itself a buffer component, refer instead to the Reaction & Applications and Biological Roles sections for practical assay use considerations.
As LMK 235 is a specific bioactive small molecule (not a process solvent or reagent), “green alternative” discussions typically relate to handling media and formulation vehicles rather than replacing the compound itself.
Greener handling choices (general):
Comparison (general; not item-specific):
Note: There is no direct “green substitute” for LMK 235’s biochemical activity; changes to the probe alter target engagement. Focus sustainability efforts on solvent choice, scale, and waste management.
No pharmacopoeial status or excipient role is provided for this item.
Context (general; no therapeutic claims):
If you require material for regulated development (GLP/GMP) or with specific impurity limits, stability studies, or formal specifications, contact technical support to discuss feasibility. Otherwise, use this material strictly for non-clinical laboratory research.
Item-specific specs (this catalog entry):
General/literature context for LMK 235-type HDAC inhibitors (for planning only; not item specifications):
Practical notes (general):
Interpretation and guidance:
This product is primarily a bioactive screening compound rather than a synthetic reagent. No manufacturer reaction applications are provided for this SKU.
Research applications (general/literature context for LMK 235):
Practical tips (general):
For synthetic reactions or named-reaction roles: not typically applicable; LMK 235 is not employed as a reagent or catalyst in preparative organic synthesis.
Not typically applicable: LMK 235 is a finished bioactive probe, not a reagent or catalyst for synthetic transformations.
Assay conditions (general/literature guidance only; not item-specific):
Expected potencies, selectivity ratios, and precise incubation parameters are assay- and isoform-dependent and should be optimized empirically. Always confirm with primary literature and pilot experiments.
Product Data safety fields:
General safety guidance for small-molecule HDAC inhibitors (literature/practice; not a substitute for SDS):
Item-specific solubility is not provided. The following is general guidance for small-molecule HDAC inhibitors like LMK 235 (literature/practice):
Small comparison (general):
Always confirm item-specific solubility and stability with small-scale tests and refer to the CoA.
From Product Data (item-specific):
General best practices (not item-specific):
Always consult the item’s CoA/SDS for any additional storage or stability notes specific to the supplied lot. Research use only.
Structural features (general/literature context):
Identity notes:
LMK 235 is a target-specific bioactive compound and is not typically used as a synthetic building block or reagent. Nevertheless, understanding its functional groups can aid in impurity analysis, derivatization for SAR, or analytical standard preparation.
General functional group considerations (literature context):
Potential laboratory uses (non-preparative):
For retrosynthesis or as a coupling partner in named reactions: not commonly applicable. If modifications are desired (e.g., SAR exploration), standard amide-coupling, hydroxamate formation, and carbamate-protection strategies are typically employed on the parent scaffold in medicinal chemistry programs.
Item-specific target data are not provided in the Product Data for this SKU.
General/literature context (for planning only):
Because no manufacturer-verified specificity data are supplied here, treat any literature claims as provisional and verify with your in-house assays.